Elanco Animal Health Incorporated (FRA:5EA)

Market Cap	10.07B +76.9%
Revenue (ttm)	3.91B +3.1%
Net Income	30.68M -82.4%
EPS	0.06 -82.8%
Shares Out	n/a
PE Ratio	328.21
Forward PE	25.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	89
Open	19.71
Previous Close	19.92
Day's Range	19.71 - 19.71
52-Week Range	7.49 - 21.90
Beta	n/a
RSI	53.14
Earnings Date	Feb 24, 2026

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 9,450
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5EA

Financial Performance

Financial numbers in USD